Dietary camphene attenuates hepatic steatosis and insulin resistance in mice

Sohee Kim, Youngshim Choi, Seoyoon Choi, Yeji Choi, Taesun Park

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective The aim of this study was to investigate the protective effects of camphene on high-fat diet (HFD)-induced hepatic steatosis and insulin resistance in mice and to elucidate its mechanism of action. Design and Methods Male C57BL/6N mice were fed with a normal diet, HFD (20% fat and 1% cholesterol of total diet), or HFD supplemented with 0.2% camphene (CPND) for 10 weeks. Results Camphene alleviated the HFD-induced increases in liver weight and hepatic lipid levels in mice. Camphene also increased circulating adiponectin levels. To examine the direct effects of camphene on adiponectin secretion, 3T3-L1 adipocytes were incubated with camphene. Consistent with in vivo result, camphene increased adiponectin expression and secretion in 3T3-L1 adipocytes. In HFD-fed mice, camphene increased hepatic adiponectin receptor expression and AMP-activated protein kinase (AMPK) activation. Concordant with the activation of adiponectin-AMPK signaling, camphene increased hepatic expression of fatty acid oxidation-related genes and decreased those of lipogenesis-related genes in HFD-fed mice. Moreover, camphene increased insulin-signaling molecules activation and stimulated glucose transporter-2translocation to the plasma membrane in the liver. Conclusions These results suggest camphene prevents HFD-induced hepatic steatosis and insulin resistance in mice; furthermore, these protective effects are mediated via the activation of adiponectin-AMPK signaling.

Original languageEnglish
Pages (from-to)408-417
Number of pages10
JournalObesity
Volume22
Issue number2
DOIs
Publication statusPublished - 2014 Feb 1

Fingerprint

Insulin Resistance
High Fat Diet
Liver
Adiponectin
AMP-Activated Protein Kinases
Adipocytes
camphene
Adiponectin Receptors
Diet
Lipogenesis
Facilitative Glucose Transport Proteins
Inbred C57BL Mouse
Genes
Fatty Acids
Fats
Cholesterol
Cell Membrane
Insulin
Lipids
Weights and Measures

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Nutrition and Dietetics

Cite this

Kim, Sohee ; Choi, Youngshim ; Choi, Seoyoon ; Choi, Yeji ; Park, Taesun. / Dietary camphene attenuates hepatic steatosis and insulin resistance in mice. In: Obesity. 2014 ; Vol. 22, No. 2. pp. 408-417.
@article{662d6ab4972f4a5893f0e03e646297eb,
title = "Dietary camphene attenuates hepatic steatosis and insulin resistance in mice",
abstract = "Objective The aim of this study was to investigate the protective effects of camphene on high-fat diet (HFD)-induced hepatic steatosis and insulin resistance in mice and to elucidate its mechanism of action. Design and Methods Male C57BL/6N mice were fed with a normal diet, HFD (20{\%} fat and 1{\%} cholesterol of total diet), or HFD supplemented with 0.2{\%} camphene (CPND) for 10 weeks. Results Camphene alleviated the HFD-induced increases in liver weight and hepatic lipid levels in mice. Camphene also increased circulating adiponectin levels. To examine the direct effects of camphene on adiponectin secretion, 3T3-L1 adipocytes were incubated with camphene. Consistent with in vivo result, camphene increased adiponectin expression and secretion in 3T3-L1 adipocytes. In HFD-fed mice, camphene increased hepatic adiponectin receptor expression and AMP-activated protein kinase (AMPK) activation. Concordant with the activation of adiponectin-AMPK signaling, camphene increased hepatic expression of fatty acid oxidation-related genes and decreased those of lipogenesis-related genes in HFD-fed mice. Moreover, camphene increased insulin-signaling molecules activation and stimulated glucose transporter-2translocation to the plasma membrane in the liver. Conclusions These results suggest camphene prevents HFD-induced hepatic steatosis and insulin resistance in mice; furthermore, these protective effects are mediated via the activation of adiponectin-AMPK signaling.",
author = "Sohee Kim and Youngshim Choi and Seoyoon Choi and Yeji Choi and Taesun Park",
year = "2014",
month = "2",
day = "1",
doi = "10.1002/oby.20554",
language = "English",
volume = "22",
pages = "408--417",
journal = "Obesity",
issn = "1930-7381",
publisher = "Wiley-Blackwell",
number = "2",

}

Dietary camphene attenuates hepatic steatosis and insulin resistance in mice. / Kim, Sohee; Choi, Youngshim; Choi, Seoyoon; Choi, Yeji; Park, Taesun.

In: Obesity, Vol. 22, No. 2, 01.02.2014, p. 408-417.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dietary camphene attenuates hepatic steatosis and insulin resistance in mice

AU - Kim, Sohee

AU - Choi, Youngshim

AU - Choi, Seoyoon

AU - Choi, Yeji

AU - Park, Taesun

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Objective The aim of this study was to investigate the protective effects of camphene on high-fat diet (HFD)-induced hepatic steatosis and insulin resistance in mice and to elucidate its mechanism of action. Design and Methods Male C57BL/6N mice were fed with a normal diet, HFD (20% fat and 1% cholesterol of total diet), or HFD supplemented with 0.2% camphene (CPND) for 10 weeks. Results Camphene alleviated the HFD-induced increases in liver weight and hepatic lipid levels in mice. Camphene also increased circulating adiponectin levels. To examine the direct effects of camphene on adiponectin secretion, 3T3-L1 adipocytes were incubated with camphene. Consistent with in vivo result, camphene increased adiponectin expression and secretion in 3T3-L1 adipocytes. In HFD-fed mice, camphene increased hepatic adiponectin receptor expression and AMP-activated protein kinase (AMPK) activation. Concordant with the activation of adiponectin-AMPK signaling, camphene increased hepatic expression of fatty acid oxidation-related genes and decreased those of lipogenesis-related genes in HFD-fed mice. Moreover, camphene increased insulin-signaling molecules activation and stimulated glucose transporter-2translocation to the plasma membrane in the liver. Conclusions These results suggest camphene prevents HFD-induced hepatic steatosis and insulin resistance in mice; furthermore, these protective effects are mediated via the activation of adiponectin-AMPK signaling.

AB - Objective The aim of this study was to investigate the protective effects of camphene on high-fat diet (HFD)-induced hepatic steatosis and insulin resistance in mice and to elucidate its mechanism of action. Design and Methods Male C57BL/6N mice were fed with a normal diet, HFD (20% fat and 1% cholesterol of total diet), or HFD supplemented with 0.2% camphene (CPND) for 10 weeks. Results Camphene alleviated the HFD-induced increases in liver weight and hepatic lipid levels in mice. Camphene also increased circulating adiponectin levels. To examine the direct effects of camphene on adiponectin secretion, 3T3-L1 adipocytes were incubated with camphene. Consistent with in vivo result, camphene increased adiponectin expression and secretion in 3T3-L1 adipocytes. In HFD-fed mice, camphene increased hepatic adiponectin receptor expression and AMP-activated protein kinase (AMPK) activation. Concordant with the activation of adiponectin-AMPK signaling, camphene increased hepatic expression of fatty acid oxidation-related genes and decreased those of lipogenesis-related genes in HFD-fed mice. Moreover, camphene increased insulin-signaling molecules activation and stimulated glucose transporter-2translocation to the plasma membrane in the liver. Conclusions These results suggest camphene prevents HFD-induced hepatic steatosis and insulin resistance in mice; furthermore, these protective effects are mediated via the activation of adiponectin-AMPK signaling.

UR - http://www.scopus.com/inward/record.url?scp=84895907338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895907338&partnerID=8YFLogxK

U2 - 10.1002/oby.20554

DO - 10.1002/oby.20554

M3 - Article

C2 - 23818423

AN - SCOPUS:84895907338

VL - 22

SP - 408

EP - 417

JO - Obesity

JF - Obesity

SN - 1930-7381

IS - 2

ER -